Länssjukhuset Ryhov är det största sjukhuset i Jönköping och Jönköpings län. Det ligger i stadens östra del, nära köpcentrumet Asecs. Ryhov har i dagsläget 25 basenheter och har cirka 10 000 personer anställda.

During the past decade, Länssjukhuset Ryhov conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 9 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 3 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Länssjukhuset Ryhov" #1 sponsor was "Karolinska Institutet" with 6 trials, followed by "Lund University Hospital" with 4 trials sponsored, "Sahlgrenska University Hospital, Sweden" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Uppsala University" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Länssjukhuset Ryhov" #1 collaborator was "The Swedish Research Council" with 5 trials as a collaborator, "Karolinska University Hospital" with 3 trials as a collaborator, "Ryhov County Hospital" with 3 trials as a collaborator, "University Hospital, Linkoeping" with 3 trials as a collaborator and "Uppsala University Hospital" with 3 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Länssjukhuset Ryhov" are "Colorectal Cancer" (3 trials), "Myocardial Infarction" (3 trials), "Acute Myocardial Infarction" (2 trials), "Breast Cancer" (2 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "Länssjukhuset Ryhov" in a lesser frequency.

Most popular intervention types in "Länssjukhuset Ryhov" are "Drug" (32 trials), "Other" (10 trials), "Procedure" (10 trials), "Behavioral" (3 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Docetaxel" (2 trials), "Evolocumab" (2 trials), "Vemurafenib" (2 trials) and "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Länssjukhuset Ryhov" are 47 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Länssjukhuset Ryhov". undefined are not yet recruiting, 14 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Länssjukhuset Ryhov, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Länssjukhuset Ryhov, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 14 trials that are defined as “Not Applicable".